Seize the Day: Expanding Opportunities for Pneumococcal Immunization in Adults (Part 2)

Credits: 0.25 AMA PRA Category 1 Credit™

Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/seize-the-day-pt-2

Overview: Adults between the ages of 18 through 64 with immunocompromising conditions due to either anatomic defects or impaired immune response are at the highest risk for invasive pneumococcal disease. They need two different pneumococcal vaccines: pneumococcal conjugate vaccine (PCV13) at the time the risk factor is recognized and pneumococcal polysaccharide vaccine (PPSV23) at least 8 weeks later. This podcast will discuss how to identify these patients at high risk for pneumococcal disease and implement guidelines for administration of pneumococcal vaccination in this population.

Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/18/2020 and they are subject to change as new information is published.

Guest: Robert H. Hopkins Jr, MD, MACP, FAAP